Founded in partnership with Mayo Clinic, Endogenex is pioneering a treatment for type 2 diabetes that targets what research now points to as a likely cause: a damaged duodenum. The company's novel, outpatient endoscopic procedure uses non-thermal pulsed electric fields (PEF) energy to treat inflamed and dysfunctional tissue associated with type 2 diabetic duodenopathy. A specialized Endogenex catheter delivers PEF to the mucosa and sub-mucosa duodenal tissue, initiating the body's natural process of cell regeneration.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/25/26	$50,000,000	Series C	Arboretum Ventures Hatteras Venture Partners Lumira Ventures Orlando Health Ventures	undisclosed